AbbVie has agreed to buy Capstan Therapeutics for up to $2.1 billion, expanding its pipeline with a potential first-in-class treatment for autoimmune diseases as well as adding a novel RNA delivery ...
Please Note: All times UK. Tables are subject to change. The BBC is not responsible for any changes that may be made. Copyright © 2026 BBC. The BBC is not ...
Please Note: All times UK. Tables are subject to change. The BBC is not responsible for any changes that may be made. Copyright © 2026 BBC. The BBC is not ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results